Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Mise à jour : Il y a 4 ans
Référence : NCT01546909

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

PRIMARY OBJECTIVES - To describe in 11 to 13-year-old children previously vaccinated with either REVAXIS or DT Polio at 6 years of age the antibody persistence against diphtheria, tetanus, and poliovirus types 1, 2 and 3 - To describe one month after a booster dose of TETRAVAC-ACELLULAIRE the immune responses against diphtheria, tetanus, and poliovirus types 1, 2 and 3 SECONDARY OBJECTIVES - To describe other parameters of the antibody persistence against diphtheria, tetanus and poliomyelitis antigens - To describe other parameters of the immune responses to diphtheria, tetanus and poliomyelitis antigens one month after a booster dose of TETRAVAC-ACELLULAIRE - To describe the safety profile of a booster dose of TETRAVAC-ACELLULAIRE


Critère d'inclusion

  • Diphtheria ,TETANUS ,Poliomyelitis

Liens